Russell Investments Group
IGMS

Russell Investments Group’s IGM Biosciences IGMS Stock Holding History

Russell Investments Group’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-131
Closed -$800 – 3834
2024
Q4 		$800 Sell
131
-790
-86% -$9.39K ﹤0.01% 3552
2024
Q3 		$15.2K Buy
921
+184
+25% +$2.02K ﹤0.01% 3009
2024
Q2 		$5.06K Buy
737
+662
+883% +$5.67K ﹤0.01% 3208
2024
Q1 		$724 Hold
75
– – ﹤0.01% 3165
2023
Q4 		$623 Sell
75
-21
-22% -$122 ﹤0.01% 3105
2023
Q3 		$802 Buy
+96
New +$814 ﹤0.01% 3359
2022
Q1 		– Sell
-25,345
Closed -$742K – 2840
2021
Q4 		$742K Sell
25,345
-9,456
-27% -$470K ﹤0.01% 2298
2021
Q3 		$2.29M Buy
34,801
+874
+3% +$66.9K ﹤0.01% 1757
2021
Q2 		$2.82M Buy
33,927
+24,998
+280% +$1.85M ﹤0.01% 1708
2021
Q1 		$684K Sell
8,929
-2,726
-23% -$248K ﹤0.01% 2393
2020
Q4 		$1.03M Buy
+11,655
New +$819K ﹤0.01% 2105

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Russell Investments Group's IGMS Position: Q1 2025 in Review

Russell Investments Group sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 131 shares — an estimated $800 sold.

Russell Investments Group first reported a position in IGMS in Q4 2020 and held it in 11 quarters. The position peaked at $2.82M in Q2 2021. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • Russell Investments Group reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • Russell Investments Group sold 131 IGM Biosciences shares in Q1 2025, an estimated $800.
  • Russell Investments Group first reported a position in IGM Biosciences in Q4 2020 and held it in 11 quarters.
  • Russell Investments Group's IGM Biosciences position peaked at $2.82M in Q2 2021.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on Russell Investments Group's 13F filing for Q1 2025, filed 13 May 2025.